|Bid||62.89 x 800|
|Ask||74.90 x 1000|
|Day's Range||68.48 - 70.35|
|52 Week Range||31.51 - 70.35|
|Beta (5Y Monthly)||1.13|
|PE Ratio (TTM)||31.84|
|Earnings Date||Feb 09, 2021 - Feb 15, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||74.50|
Diodes Incorporated (Nasdaq: DIOD) today announced management will present at the following virtual financial conferences.
\\-- PrEP is part of the ongoing efforts by Gilead Canada to end the HIV epidemic--MISSISSAUGA, ON, Dec. 1, 2020 /CNW/ - Gilead Sciences Canada, Inc.
Biotech stocks are likely to remain in focus through year end amid news surrounding COVID-19 vaccines and treatments.